Zafgen
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Center Plz Ste 610, Boston, Massachuse...Phone Number
(617) 622-4003Website
www.zafgen.comRevenue
<$5 MillionStock Symbol
ZFGNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Zafgen
Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from metabolic diseases comprising type 2 diabetes and obesity. Zafgen, Inc. was founded in 2005 and is based in Boston, Massachusetts.Explore more
Zafgen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zafgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Zafgen is spiking on competitors!
Earning: See what the market has to say on Zafgen recently announced quarterly report
Product Launch: Get notified when Zafgen launches new products
Zafgen, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Zafgen
Check if Zafgen has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Zafgen has new funding data
Click to see if Zafgen had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Zafgen
Find 3 more new buyers
Company Profile Activity
Activity Insights
Zafgen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zafgen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zafgen.
Zafgen financials insights
Gather financial insights about Zafgen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$5.2M
2010
Series B
$28M
2011
Series C
$33M
2012
Series D
$21M
2013
Other Financing Round
$45M
2014
Debt
$20M
Stock Offering
$96M
Zafgen Tech Stack
A closer look at the technologies used by Zafgen
Most Recent Scoops
Hiring Plans
Zafgen has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Prostate Cancer, Hematology, Clinical Research, Biotechnology, Pharmaceuticals, Oncology, and Outcomes Research.
Hiring Plans
Hiring Plans
Zafgen has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Continuous Monitoring, Quality Management, International Standards, ISO 14971 Standard, ISO 13485 Standard, and Regulatory Requirements.
Hiring Plans
Hiring Plans
Zafgen has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Tableau, Amazon AWS, Ruby on Rails, Veeva Systems, JavaScript, Databricks, and GitLab with an increased focus that include Agile Management, and experience with Prototyping, Motion Graphics, UI/UX Research, User Interface (UI) Design, Human-Computer Interaction, and Visualization.
Hiring Plans
Hiring Plans
Zafgen has more open roles in Information Technology than it has had at any time in the past 12 months. Technologies mentioned include: Sectigo, ServiceNow, OpenAI, Microsoft Entra, Unix, Microsoft Azure, and Jira. Areas of expertise include: Cloud Security Architecture, Authentications, Identity And Access Management, DevSecOps, Active Directory, ServiceNow, and Data Management Platforms.
Hiring Plans
Hiring Plans
Hiring Plans
Zafgen News & Media
SwanBio Therapeutics Expands Board of Directors with Appointments of Proven Industry Leaders
PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics Expands Board of Directors with Appointments of Proven Industry LeadersChondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
- Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020 - Company signed $80 million in private placement financing with biotechnology focused institutional investors - New Board Chair, Chief Medical Officer and Chief Financial Officer appointedZafgen Reports Fourth Quarter and Full Year 2019 Financial Results
Zafgen and Chondrial Therapeutics previously announced a definitive merger agreementZafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics
Zafgen stumbled in clinical trials testing its experimental therapies for metabolic diseases. Going forward, it will have a new name, new management, and a mitochondrial disorder drug from another company. Boston-based Zafgen (NASDAQ: ZFGN) has entered a merger agreement with Chondrial Therapeutics, a rare disease drug developer just entering the clinic. Chondrial shareholders will own […]
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zafgen
Sign Up For FreeTo access detailed company insights
Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from metabolic diseases comprising type 2 diabetes and obesity. Zafgen, Inc. was founded in 2005 and is based in Boston, Massachusetts.... Read More
